• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体汞的2,3-二巯基丙磺酸钠激发试验。III. 接触氯化亚汞后的尿汞

Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride.

作者信息

Maiorino R M, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut K M, Aposhian M M, Dart R C, Woods J S, Ostrosky-Wegman P, Gonsebatt M E, Aposhian H V

机构信息

Department of Pharmacology, Centro de Investigacion Biomedica Del Noreste, Instituto Mexicano Del Seguro Social, Monterrey, Mexico.

出版信息

J Pharmacol Exp Ther. 1996 May;277(2):938-44.

PMID:8627576
Abstract

The sodium salt of 2,3-dimercaptopropane-1-sulfonic acid (Dimaval; DMPS) challenge test has been given previously to humans exposed to elemental mercury (vapor) or mercuric salts, but not mercurous salts. The test (300 mg p.o., after an 11-hr fast) was given to 11 factory workers who make a skin lotion that contains mercurous chloride, eight users of the skin lotion and nine controls. Urines were analyzed for total mercury by using cold vapor atomic absorption spectrophotometry. The mercury excreted for 6 hr before and 6 hr after DMPS treatment was 113 micrograms +/- 26 and 5037 micrograms +/- 682 S.E.M. for the skin lotion makers; 16.2 micrograms +/- 3.4 and 1410 micrograms +/- 346 S.E.M. for the skin lotions users; and 0.49 micrograms +/- 0.11 and 18.4 micrograms +/- 7.1 S.E.M. for the controls, respectively. The increases in urinary mercury resulting from the DMPS challenge test were 45-, 87- and 38-fold, respectively. The results demonstrate that, in humans exposed to mercurous chloride, DMPS increases the urinary excretion of mercury and that the DMPS/mercury challenge test is of value for a more realistic estimation of mobilizable mercury. An attempt to associate genotoxicity, as indicated by micronuclei content in buccal cells, with mercury exposure was inconclusive, perhaps because of the small number of subjects.

摘要

2,3-二巯基丙烷-1-磺酸钠(二巯丙磺钠;DMPS)激发试验先前已应用于暴露于元素汞(蒸气)或汞盐但未暴露于亚汞盐的人群。该试验(禁食11小时后口服300毫克)应用于11名生产含氯化亚汞的护肤液的工厂工人、8名该护肤液使用者和9名对照者。通过冷蒸气原子吸收分光光度法分析尿液中的总汞。对于护肤液生产者,DMPS治疗前6小时和治疗后6小时排出的汞分别为113微克±26微克和5037微克±682微克标准误;对于护肤液使用者,分别为16.2微克±3.4微克和1410微克±346微克标准误;对于对照者,分别为0.49微克±0.11微克和18.4微克±7.1微克标准误。DMPS激发试验导致的尿汞增加分别为45倍、87倍和38倍。结果表明,在暴露于氯化亚汞的人群中,DMPS可增加汞的尿排泄量,且DMPS/汞激发试验对于更实际地评估可动员汞具有价值。试图将颊细胞中的微核含量所表明的遗传毒性与汞暴露联系起来的尝试尚无定论,可能是因为受试者数量较少。

相似文献

1
Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride.人体汞的2,3-二巯基丙磺酸钠激发试验。III. 接触氯化亚汞后的尿汞
J Pharmacol Exp Ther. 1996 May;277(2):938-44.
2
DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride.二巯基丙磺酸钠(2,3-二巯基丙烷-1-磺酸钠,二巯丙磺钠)可降低接触氯化亚汞的人体中的汞负荷。
J Pharmacol Exp Ther. 1998 Oct;287(1):8-12.
3
Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
J Pharmacol Exp Ther. 1995 Jan;272(1):264-74.
4
DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.二巯基丙磺酸钠-砷激发试验。I:给予二巯基丙磺酸钠的人体中一甲基胂酸尿排泄增加。
J Pharmacol Exp Ther. 1997 Jul;282(1):192-200.
5
Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate.通过二巯基丙烷磺酸盐螯合作用对大鼠体内汞负荷的评估。
J Pharmacol Exp Ther. 1988 May;245(2):479-84.
6
Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.2,3-二巯基丙烷-1-磺酸盐(DMPS)和内消旋-2,3-二巯基琥珀酸(DMSA)对暴露于无机汞的正常大鼠和单侧肾切除大鼠汞肾排泄的影响。
J Pharmacol Exp Ther. 1993 Nov;267(2):791-800.
7
Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.亚硒酸钠与氯化汞同时给药会降低二巯基丁二酸(DMSA)和二巯基丙磺酸钠(DMPS)在大鼠体内排汞的效果。
Toxicol Lett. 2005 Jan 15;155(1):97-102. doi: 10.1016/j.toxlet.2004.08.014.
8
Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.12例皮肤氯化亚汞(甘汞)暴露患者的尿汞情况:2,3-二巯基丙磺酸钠(DMPS)治疗的效果
J Toxicol Clin Toxicol. 1997;35(6):653-5. doi: 10.3109/15563659709001249.
9
Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
Int J Occup Med Environ Health. 2000;13(2):131-46.
10
Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans.
J Pharmacol Exp Ther. 1991 Nov;259(2):808-14.

引用本文的文献

1
Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults.用于治疗蛇咬伤中毒的二巯丙磺钠口服疗法的开发:一项针对肯尼亚健康成年人的1期开放标签剂量递增安全性试验和药代动力学分析。
EBioMedicine. 2025 Mar;113:105600. doi: 10.1016/j.ebiom.2025.105600. Epub 2025 Feb 27.
2
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults).TRUE-1:用于蛇咬伤中毒的重新利用的二巯丙醇试验1期(肯尼亚健康成年人的安全性、耐受性、药代动力学和药效学)
Wellcome Open Res. 2022 Mar 14;7:90. doi: 10.12688/wellcomeopenres.17682.1. eCollection 2022.
3
Recommendations for provoked challenge urine testing.激发性挑战尿检测建议。
J Med Toxicol. 2013 Dec;9(4):318-25. doi: 10.1007/s13181-013-0350-7.
4
Mercury exposure aboard an ore boat.一艘运矿船上的汞暴露情况。
Environ Health Perspect. 2004 Jun;112(8):910-3. doi: 10.1289/ehp.6798.
5
Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS).
Environ Health Perspect. 1998 Aug;106 Suppl 4(Suppl 4):1017-25. doi: 10.1289/ehp.98106s41017.